http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2040770-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d249a4698cb89e3eb811d2f47114b5e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bd425fa2db4ca73612800b68654b931 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
| filingDate | 1991-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62807667ec964bed62150bf0a905b8e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d963a30e476fd44a1521799a0b8e87f |
| publicationDate | 1991-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2040770-A1 |
| titleOfInvention | Administration of monoclonal antibodies against respiratory viruses |
| abstract | ABSTRACT OF THE DISCLOSURE A process for the prophylaxis and/or treatment of respiratory viruses which comprises administering topically or systemically, to an animal, at least one monoclonal antibody against at least one respiratory virus. The present invention is particularly applicable to the prophylaxis of respiratory syncytial virus, or RSV, by administering at least one monoclonal antibody against a fusion protein of respiratory syncytial virus . |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922344-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5534411-A |
| priorityDate | 1990-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.